MC1553A1 - Proteine d'interferon immunitaire humain et son procede de production - Google Patents

Proteine d'interferon immunitaire humain et son procede de production

Info

Publication number: MC1553A1
Authority: MC; Monaco
Prior art keywords: producing; same; human immune; immune interferon; interferon protein
Prior art date: 1982-11-22

Application number

MC831664A

Other languages

English (en)

French (fr)

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-11-22

Filing date

1983-11-21

Publication date

1984-08-31

1983-11-21 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

1984-08-31 Publication of MC1553A1 publication Critical patent/MC1553A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)

MC831664A 1982-11-22 1983-11-21 Proteine d'interferon immunitaire humain et son procede de production MC1553A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/JP1982/000445 WO1984002129A1 (en)	1982-11-22	1982-11-22	Human immune interferon protein and process for its preparation

Publications (1)

Publication Number	Publication Date
MC1553A1 true MC1553A1 (fr)	1984-08-31

Family

ID=13762365

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MC831664A MC1553A1 (fr)	1982-11-22	1983-11-21	Proteine d'interferon immunitaire humain et son procede de production

Country Status (18)

Country	Link
EP (1)	EP0110044A1 (el)
JP (4)	JPS59186995A (el)
KR (1)	KR920001377B1 (el)
AU (1)	AU570219B2 (el)
DK (1)	DK164063C (el)
ES (1)	ES8504938A1 (el)
FI (1)	FI81832C (el)
GR (1)	GR79035B (el)
HU (1)	HU209152B (el)
IE (1)	IE57053B1 (el)
IL (1)	IL69791A (el)
MC (1)	MC1553A1 (el)
NO (1)	NO169725C (el)
NZ (1)	NZ205667A (el)
PH (1)	PH20024A (el)
PT (1)	PT77573B (el)
WO (1)	WO1984002129A1 (el)
ZA (1)	ZA837057B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5582824A (en) *	1981-10-19	1996-12-10	Genentech, Inc.	Recombinant DES-CYS-TYR-CYS human immune interferon
WO1984002129A1 (en) *	1982-11-22	1984-06-07	Takeda Chemical Industries Ltd	Human immune interferon protein and process for its preparation
DE3484374D1 (de) *	1983-08-04	1991-05-08	Green Cross Corp	Gamma-interferonzusammensetzung.
JPS6034919A (ja) *	1983-08-04	1985-02-22	Green Cross Corp:The	ガンマ・インタ−フェロン組成物
ZA846554B (en) *	1983-09-20	1985-04-24	Hoffmann La Roche	Immune interferon and method for its purification
FR2556365B1 (fr) *	1983-12-09	1987-07-31	Transgene Sa	Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
MX9203641A (es) *	1983-12-16	1992-07-01	Genentech Inc	Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4855238A (en)	1983-12-16	1989-08-08	Genentech, Inc.	Recombinant gamma interferons having enhanced stability and methods therefor
US4499014A (en) *	1984-02-07	1985-02-12	Interferon Sciences, Inc.	Method for purifying gamma-interferon
DE3426077A1 (de) *	1984-07-14	1986-01-23	Dr. Karl Thomae Gmbh, 7950 Biberach	Monoklonale antikoerper gegen humanes ifn-(gamma), diese antikoerper produzierende hybridzellinien, verwendung der neuen antikoerper und verfahren zu deren herstellung
DE3432196A1 (de) *	1984-09-01	1986-03-06	Boehringer Ingelheim International GmbH, 6507 Ingelheim	Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
JPH0653067B2 (ja) *	1984-09-11	1994-07-20	武田薬品工業株式会社	新規ハイブリドーマおよびその製造法
GB2164650A (en) *	1984-09-25	1986-03-26	Fujisawa Pharmaceutical Co	Process for production of y-interferon
US4946674A (en) *	1984-10-05	1990-08-07	Bioferon Biochemische Substanzen Gmbh & Co.	Process for treatment of rheumatic diseases
US4873312A (en) *	1985-04-25	1989-10-10	Amgen	Method for purifying interferon and composition of matter produced thereby
US4828830A (en) *	1986-01-24	1989-05-09	Genentech, Inc.	Method and composition for prophylaxis and treatment of viral infections
GB8719108D0 (en) *	1987-08-12	1987-09-16	Natural Environment Res	Expression vectors
DE3829180A1 (de) *	1988-08-29	1990-03-08	Boehringer Ingelheim Int	Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
EP1231943A1 (en)	1999-11-12	2002-08-21	Maxygen Holdings Ltd	Interferon gamma conjugates
CN1309423C (zh)	1999-11-12	2007-04-11	马克西根控股公司	干扰素γ偶联物
US6958388B2 (en)	2001-04-06	2005-10-25	Maxygen, Aps	Interferon gamma polypeptide variants
US7038015B2 (en)	2001-04-06	2006-05-02	Maxygen Holdings, Ltd.	Interferon gamma polypeptide variants
US7524931B2 (en)	2002-07-03	2009-04-28	Maxygen Holdings Ltd.	Full-length interferon gamma polypeptide variants
JP2008525424A (ja)	2004-12-23	2008-07-17	モルメドエスピーエー	複合生成物
KR20150008503A (ko)	2007-10-30	2015-01-22	제넨테크, 인크.	양이온 교환 크로마토그래피에 의한 항체 정제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL65475A0 (en) *	1981-04-17	1982-07-30	Meloy Lab	Production of immune interferon and its mrna
US4376821A (en) *	1981-04-17	1983-03-15	Meloy Laboratories, Inc.	Production of human IFN-gamma (immune) interferon
AU561343B2 (en) *	1981-10-19	1987-05-07	Genentech Inc.	Human immune interferon by recombinant dna
JPS58110548U (ja) *	1982-01-22	1983-07-28	株式会社東海理化電機製作所	自動車用ミラ−の駆動装置
EP0088540A3 (en) *	1982-02-22	1984-10-17	Biogen, Inc.	Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) *	1982-03-24	1983-06-15	Takeda Chemical Industries Ltd	Novel dna and use thereof
JPH0787797B2 (ja) *	1982-05-20	1995-09-27	サントリー株式会社	ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) *	1982-09-22	1987-07-21	Takeda Chemical Industries, Ltd.	Novel peptide and use thereof
WO1984002129A1 (en) *	1982-11-22	1984-06-07	Takeda Chemical Industries Ltd	Human immune interferon protein and process for its preparation
JP2526750B2 (ja) *	1991-07-30	1996-08-21	株式会社ユアサコーポレーション	リチウム二次電池

1982
- 1982-11-22 WO PCT/JP1982/000445 patent/WO1984002129A1/ja unknown
1983
- 1983-09-21 NZ NZ205667A patent/NZ205667A/en unknown
- 1983-09-21 IE IE2216/83A patent/IE57053B1/en not_active IP Right Cessation
- 1983-09-21 EP EP83109403A patent/EP0110044A1/en not_active Withdrawn
- 1983-09-21 IL IL6979183A patent/IL69791A/en not_active IP Right Cessation
- 1983-09-21 PH PH29570A patent/PH20024A/en unknown
- 1983-09-21 AU AU19346/83A patent/AU570219B2/en not_active Ceased
- 1983-09-21 DK DK430683A patent/DK164063C/da not_active IP Right Cessation
- 1983-09-22 JP JP58176090A patent/JPS59186995A/ja active Granted
- 1983-09-22 ZA ZA837057A patent/ZA837057B/xx unknown
- 1983-09-22 KR KR1019830004437A patent/KR920001377B1/ko not_active IP Right Cessation
- 1983-09-29 FI FI833525A patent/FI81832C/fi not_active IP Right Cessation
- 1983-10-07 NO NO833659A patent/NO169725C/no unknown
- 1983-10-27 PT PT77573A patent/PT77573B/pt not_active IP Right Cessation
- 1983-11-10 GR GR72942A patent/GR79035B/el unknown
- 1983-11-21 HU HU834044A patent/HU209152B/hu not_active IP Right Cessation
- 1983-11-21 ES ES527414A patent/ES8504938A1/es not_active Expired
- 1983-11-21 MC MC831664A patent/MC1553A1/xx unknown
1984
- 1984-03-21 JP JP59052243A patent/JPS59220190A/ja active Pending
1987
- 1987-10-08 JP JP62255867A patent/JPS63211240A/ja active Granted
1994
- 1994-04-25 JP JP6086570A patent/JPH06316532A/ja active Pending

Also Published As

Publication number	Publication date
FI833525A (fi)	1984-05-23
IE57053B1 (en)	1992-04-08
JPS6411639B2 (el)	1989-02-27
WO1984002129A1 (en)	1984-06-07
FI81832B (fi)	1990-08-31
JPS59220190A (ja)	1984-12-11
FI833525A0 (fi)	1983-09-29
NO169725C (no)	1992-07-29
DK430683D0 (da)	1983-09-21
IE832216L (en)	1984-05-22
IL69791A (en)	1994-05-30
PT77573B (en)	1986-03-18
JPS59186995A (ja)	1984-10-23
ES527414A0 (es)	1985-04-16
DK430683A (da)	1984-05-23
JPS63211240A (ja)	1988-09-02
JPH06316532A (ja)	1994-11-15
AU1934683A (en)	1984-06-28
NO169725B (no)	1992-04-21
GR79035B (el)	1984-10-02
ZA837057B (en)	1984-04-25
KR840006676A (ko)	1984-12-01
NO833659L (no)	1984-05-23
DK164063C (da)	1992-09-28
NZ205667A (en)	1987-01-23
EP0110044A1 (en)	1984-06-13
ES8504938A1 (es)	1985-04-16
DK164063B (da)	1992-05-04
AU570219B2 (en)	1988-03-10
KR920001377B1 (ko)	1992-02-11
HU209152B (en)	1994-03-28
PH20024A (en)	1986-09-01
JPH0536414B2 (el)	1993-05-31
FI81832C (fi)	1990-12-10
PT77573A (en)	1983-11-01

Publication	Publication Date	Title
MC1553A1 (fr)	1984-08-31	Proteine d'interferon immunitaire humain et son procede de production
FR2556210B1 (fr)	1988-04-15	Prothese veineuse et son procede d'obtention
FR2490675B1 (fr)	1985-11-15	Production microbienne d'interferon de fibroplaste humain
PT84674A (en)	1987-05-01	Therapeutical system and process for the production thereof
DE3485723D1 (de)	1992-06-17	Verfahren und signalsequenz fuer die extrazellulare herstellung von proteinmaterial.
MA20739A1 (fr)	1987-04-01	Procede de preparation d'hydroxyalkylxanthines tertiaires
MA21323A1 (fr)	1989-04-01	Dihydrate d'azithromycine et son procede de preparation.
KR890700172A (ko)	1989-03-10	금속-제2상 복합체 생산방법 및 그 생산물
GB2096146B (en)	1984-08-08	Process for the production of human antibodies
HUT43104A (en)	1987-09-28	Process for producing human antibodies
MC1499A1 (fr)	1983-11-17	Interferon immun humain homogene et procede pour sa preparation
DE3466539D1 (en)	1987-11-05	4'-flavonecarboxylic acids, process for their preparation and their therapeutical use
BE895961A (fr)	1983-06-16	Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
FR2567540B1 (fr)	1988-10-14	Procede de preparation d'un interferon leucocytaire humain alpha-2
HUT47640A (en)	1989-03-28	Process for producing human reg protein
FR2550802B1 (fr)	1986-04-11	Procede de production d'interleukine 1 humaine et medicaments correspondants
EP0308336A3 (en)	1990-05-09	Process for the production of human pro-apolipoprotein a-i-like proteins
HUT40576A (en)	1987-01-28	Process for producing human leucocite interferon
GB9022152D0 (en)	1990-11-21	Improved methods for the production of proteins
GB2127024B (en)	1986-04-23	Modified proteins and process for the production thereof
FR2610924B1 (fr)	1990-05-04	Procede de preparation d'hydroxybiphenyles
IL74094A0 (en)	1985-04-30	Highly solubilised protein and production thereof
FR2541288B1 (fr)	1986-12-26	Derives de 3-o-acyl-4''-deoxydesmycosine et leur production
RO82395A (ro)	1983-08-03	Procedeu pentru prepararea unor esteri alchilici alfa-beta-nesaturati
FR2492663B1 (fr)	1985-11-08	Produit medicamenteux regulateur du t-systeme de l'immunite et son procede de preparation

Legal Events

Date	Code	Title	Description
1991-11-25	YP	Annual fee paid